Lincoln Pharmaceuticals Ltd (LINCOLN) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531633 | NSE: LINCOLN | Pharmaceuticals & Drugs | Small Cap

Lincoln Pharma Share Price

492.70 -3.70 -0.75%
as on 05-Dec'25 16:59

Lincoln Pharmaceuticals Ltd (LINCOLN) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531633 | NSE: LINCOLN | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Lincoln Pharma

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

incoln Pharmaceuticals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
12.43
Market Cap:
994.3 Cr.
52-wk low:
491
52-wk high:
975

Is Lincoln Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Lincoln Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lincoln Pharmaceuticals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 19.8%18.6%18.3%21.7%21.8%25.2%24.3%21.8%22.5%17.6%-
Value Creation
Index
0.40.30.30.60.60.80.70.60.60.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 311304325353376423472510581623632
Sales YoY Gr.--2.1%6.8%8.6%6.5%12.5%11.6%8.1%13.8%7.4%-
Adj EPS 12.213.615.121.821.630.733.932.344.537.439.9
YoY Gr.-11.8%10.8%44.5%-0.9%42.1%10.5%-4.7%37.6%-15.9%-
BVPS (₹) 80.494.8109.8131.3152.3182.9216.1250.9296335.3357.4
Adj Net
Profit
19.927.230.243.643.261.56864.889.17580
Cash Flow from Ops. 28.917.821.351.170.769.476.239.263.293-
Debt/CF from Ops. 2.132.60.70.1000.100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8%10.6%9.7%7.4%
Adj EPS 13.3%11.6%3.4%-15.9%
BVPS17.2%17.1%15.8%13.3%
Share Price 9.8% 16.3% 12.3% -46.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
15.916.614.818.115.218.31713.916.311.911.5
Op. Profit
Mgn %
10.61414.217.115.920.620.317.517.316.315.8
Net Profit
Mgn %
6.499.312.411.514.614.412.715.41212.7
Debt to
Equity
0.50.30.30.10000000
Working Cap
Days
168198221223227227226231224232107
Cash Conv.
Cycle
9393949080636479857677

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Lincoln Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 39.9 39.9
TTM Sales (₹ Cr.) 632 632
BVPS (₹.) 357.4 357.4
Reserves (₹ Cr.) 696 696
P/BV 1.39 1.39
PE 12.43 12.43
From the Market
52 Week Low / High (₹) 491.00 / 975.00
All Time Low / High (₹) 8.05 / 975.00
Market Cap (₹ Cr.) 994
Equity (₹ Cr.) 20
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Lincoln Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Lincoln Pharma - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Lincoln Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales311304325353376423472510581623
Operating Expenses 278262279293317336377421481522
Manufacturing Costs2932394548697896114133
Material Costs189158152157163155170179204203
Employee Cost 2735484855638093103112
Other Costs 34374142504950536073
Operating Profit 3342466059879589100101
Operating Profit Margin (%) 10.5%13.9%14.1%17.1%15.8%20.6%20.2%17.5%17.2%16.3%
Other Income 636712610223422
Interest 6544221212
Depreciation 344558891113
Exceptional Items 0000000000
Profit Before Tax 30364358648496100122109
Tax 881012142127282927
Profit After Tax 22273347506269739382
PAT Margin (%) 7.0%9.0%10.1%13.2%13.2%14.7%14.7%14.3%16.1%13.2%
Adjusted EPS (₹)13.313.716.423.324.831.134.636.446.641.1
Dividend Payout Ratio (%)8%9%9%6%6%5%4%4%4%4%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 131190220263304366433502593672
Share Capital 16202020202020202020
Reserves 115170200243284346413482573652
Minority Interest0000000000
Debt59515532402210
Long Term Debt9762100000
Short Term Debt50444930402210
Trade Payables21253536425771517285
Others Liabilities 31333247617879815965
Total Liabilities 242299341378412501585636725822

Fixed Assets

Gross Block807291101108142171197237252
Accumulated Depreciation174812173139475770
Net Fixed Assets 6368838891111132151179182
CWIP 37020216734
Investments 2036394660819791139174
Inventories25323629384773707779
Trade Receivables75799611391112115135161166
Cash Equivalents 5587111318341322
Others Assets 51727891121136134148152195
Total Assets 242299341378412501585636725822

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 29182151716976396393
PBT 30364358648496100122109
Adjustment 8887551-0-171
Changes in Working Capital -3-17-2131502-31-169
Tax Paid -6-9-9-17-14-19-24-30-26-26
Cash Flow From Investing Activity -40-26-14-22-29-64-78-37-57-79
Capex -33-17-9-11-6-9-45-14-40-19
Net Investments 0-101-6-15-44-23-4-3-30
Others -71-5-5-8-11-9-19-15-30
Cash Flow From Financing Activity 118-4-30-38-6-3-5-5-6
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 8-2-1-4-3-1-1000
Interest Paid -6-5-4-4-2-1-1-1-1-2
Dividend Paid -2-2-3-4-70-3-3-3-4
Others 10174-18-26-42-0-1-1
Net Cash Flow -0-04-14-1-4-218

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)17.9417.0916.0119.3517.4818.5617.3515.5917.0413.02
ROCE (%)19.8318.6318.2821.6821.8125.2124.2921.8222.5317.55
Asset Turnover Ratio1.451.141.021.010.990.960.910.880.890.84
PAT to CFO Conversion(x)1.320.670.641.091.421.111.10.530.681.13
Working Capital Days
Receivable Days919198105968583858991
Inventory Days25343833313544494444
Payable Days3353728287116138124110141

Lincoln Pharmaceuticals Ltd Stock News

Lincoln Pharmaceuticals Ltd FAQs

The current trading price of Lincoln Pharma on 05-Dec-2025 16:59 is ₹492.7.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Lincoln Pharma stood at ₹994.3.
The latest P/E ratio of Lincoln Pharma as of 04-Dec-2025 is 12.43.
The latest P/B ratio of Lincoln Pharma as of 04-Dec-2025 is 1.39.
The 52-week high of Lincoln Pharma is ₹975.0 and the 52-week low is ₹491.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lincoln Pharma is ₹632.2 ( Cr.) .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters. There are three different buildings for tablets, capsules and injectables and also a separate building for quality control.

An ultramodern laboratory with state-of-the-art equipments ensures in-house quality assurance of each of the products. The products are designed for all therapeutic segments with a special emphasis on gynecological and orthopedic specialties.

Group of Companies

  • Lincoln Parenterals
  • Karnavati Distributors
  • Down Town Travels
  • Shelavi Paper Mills

Product of the company

  • Tablets 
  • Capsules
  • Injectables
  • Syrups
  • Ointments

Certification

  • WHO-GMP standard
  • ISO 9002 certification 
  • Export House certification
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×